Intas Pharmaceuticals
Kshitiz Gadodia is a seasoned financial professional with extensive experience in the pharmaceutical and finance sectors. Currently serving as the Chief Financial Officer at Intas Pharmaceuticals since April 2024, Kshitiz previously held the position of Vice President in the Business Finance Group at Lupin from June 2021 to April 2024. Prior to that, Kshitiz worked at Novartis as Head of Global BPA Finance for Manufacturing Operations from October 2020 to June 2021. Kshitiz's career at Dr. Reddy's Laboratories spanned nearly a decade, where roles included Senior Director Finance, Director Finance, and Associate Director, Finance. Kshitiz also worked as Team Manager in Finance at Shell from March 2009 to July 2011 and as Finance Controller at Tolaram Group from November 2003 to December 2008. Kshitiz holds a Chartered Accountant designation from The Institute of Chartered Accountants of India and a B.Com (Hons) degree in Commerce from Delhi University.
This person is not in the org chart
This person is not in any teams
Intas Pharmaceuticals
2 followers
Intas Pharmaceuticals Ltd. is an India-based pharmaceutical formulation development, manufacturing and marketing company. The Company offers products for the treatment of cardiovascular system (CVS), diabetology, gynecology, infertility, respiratory care, gastroenterology, pain management, as well as other therapeutic segments. Its pharma products include ACUTROL-400, ADAPEN GEL, ADIFLOX, ALZIL 10, ALZIL M 10 and AMITONE 10. The Company's biologics products include Albucel 20%, Epofit, Erykine, Factocel VIII, MabTas, Neukine and Neupeg. It range of products for animal health includes AC-Vet, AC-Vet Forte, AC-Vet Max, Alzonic, Anistamin, Benezepril, Bufzone, Calshakti Platina and Carprofen Inj. The Company offers approximately 10 biologic products and is engaged in research and development in chronic disease areas, such as oncology (cancer), rheumatology, auto-immune, nephrology, ophthalmology and plasma derived product based therapies.